少数族裔女性参与妇科肿瘤临床试验意愿的影响因素
本研究在美国南部农村学术医疗中心对156名妇科肿瘤患者进行前瞻性问卷调查,评估种族与参与临床试验意愿的关系及教育干预的影响。结果显示初始仅35%愿意参与,教育后升至82%,但白人和高教育程度者提升更显著,提示需针对少数族裔采用不同招募策略。
要点
- 初始仅35%的妇科肿瘤患者愿意参与临床试验,教育后升至82%。
- 种族、年龄、婚姻、教育、癌症类型等与初始参与意愿无关。
- 教育后白人和高教育程度者意愿提升更显著,少数族裔提升较弱。
核心结论
- 教育干预可提高所有亚组参与临床试验的意愿,但少数族裔的提升幅度较小,提示需针对少数族裔采用不同的招募工具。
研究设计与样本
- 单中心前瞻性调查研究,纳入156名当前或既往诊断为妇科恶性肿瘤的女性,50%白人、50%非白人,中位年龄63岁,子宫内膜癌最常见(48%)。
主要发现
- 初始筛查仅35%愿意参与临床试验。
- 参与意愿与种族、年龄、婚姻状况、教育水平、癌症类型、分期或治疗方式无关。
- 提供额外教育信息后,愿意参与的比例提高至82%。
- 教育后,白人女性和教育程度较高者参与临床试验的意愿显著高于少数族裔和教育程度较低者。
关键数值与推荐
- 少数族裔组包括35%非西班牙裔黑人、9%西班牙裔、4%亚裔和2%其他。
- 使用经验证的态度随机试验问卷(ARTQ)评估参与临床试验的意愿。
临床怎么用
- 在妇科肿瘤临床试验招募中,应针对少数族裔和教育程度较低者设计差异化的教育工具以提高参与意愿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Given the disparity that exists in enrollment of minorities to oncology clinical trials, the objective of our study was to assess whether race is associated with willingness to participate in gynecologic oncology clinical trials in a rural Southern academic medicine setting. Our secondary aim was to determine whether willingness to participate is impacted by an educational intervention. METHODS: A single institution prospective survey study was performed at an academic medical center. Women presenting to the gynecologic oncology clinic with a current or prior diagnosis of gynecologic malignancy were approached to participate. The validated Attitudes to Randomized Trials Questionnaire (ARTQ) assessed willingness to participate in clinical trials. Relevant demographic and clinical data were abstracted. Characteristics were compared between those willing and unwilling to participate in clinical trials with a chi-square test for categorical variables and Wilcoxon rank sum tests for continuous data. RESULTS: We enrolled 156 participants (50% White, 50% non-White) from May 2017 to January 2018. The minority group included 35% non-Hispanic Black, 9% Hispanic, 4% Asian, and 2% other. Median age was 63 years with endometrial cancer being the most common diagnosis (48%). On initial screen, only 35% were willing to participate in a clinical trial. Willingness to participate did not differ between race, age, marital status, education level, cancer type, stage, or mode of treatment. Rates improved to 82% after being provided additional educational information. Following education, White women and those with more education were significantly more willing to participate in clinical trials than their minority and less educated counterparts. CONCLUSIONS: Willingness to participate improved among all sub-categories following an educational intervention. The increase in willingness was less robust among racial and ethnic minorities, suggesting that different tools are needed for recruitment of minorities to gynecologic oncology clinical trials.
引用
- Patel SN, Staples JN, Garcia C, et al. Are ethnic and racial minority women less likely to participate in clinical trials? Gynecol Oncol. 2020. PMID: 32253046. doi:10.1016/j.ygyno.2020.01.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。